Molecular Partners AG (MOLN)
USD 5.3
(-1.67%)
USD 5.3
(-1.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -40.8 Million CHF | -129.4% |
| 2022 | 138.8 Million CHF | 399.23% |
| 2021 | -46.38 Million CHF | 0.73% |
| 2020 | -46.73 Million CHF | -102.17% |
| 2019 | -23.11 Million CHF | -340.54% |
| 2018 | -5.24 Million CHF | -339.15% |
| 2017 | 2.19 Million CHF | -74.09% |
| 2016 | 8.46 Million CHF | -69.7% |
| 2015 | 27.95 Million CHF | 5.67% |
| 2014 | 26.45 Million CHF | -15.2% |
| 2013 | 31.19 Million CHF | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -11.53 Million CHF | -1.5% |
| 2024 Q1 | -11.36 Million CHF | -4.49% |
| 2023 FY | -40.8 Million CHF | -129.4% |
| 2023 Q1 | -9.64 Million CHF | -1.34% |
| 2023 Q3 | -9.06 Million CHF | 19.18% |
| 2023 Q4 | -10.87 Million CHF | -19.99% |
| 2023 Q2 | -11.21 Million CHF | -16.3% |
| 2022 Q2 | -823 Thousand CHF | -100.52% |
| 2022 Q1 | 158.3 Million CHF | 1582.27% |
| 2022 FY | 138.8 Million CHF | 399.23% |
| 2022 Q4 | -9.51 Million CHF | -3.91% |
| 2022 Q3 | -9.15 Million CHF | -1012.88% |
| 2021 Q3 | -8.15 Million CHF | 33.18% |
| 2021 Q2 | -12.2 Million CHF | 20.48% |
| 2021 Q1 | -15.34 Million CHF | 7.68% |
| 2021 FY | -46.38 Million CHF | 0.73% |
| 2021 Q4 | -10.68 Million CHF | -30.96% |
| 2020 FY | -46.73 Million CHF | -102.17% |
| 2020 Q1 | -9.55 Million CHF | -8.16% |
| 2020 Q2 | -8.06 Million CHF | 15.6% |
| 2020 Q3 | -12.48 Million CHF | -54.73% |
| 2020 Q4 | -16.62 Million CHF | -33.18% |
| 2019 Q1 | -2.72 Million CHF | 72.2% |
| 2019 FY | -23.11 Million CHF | -340.54% |
| 2019 Q4 | -8.83 Million CHF | 0.0% |
| 2019 Q3 | -8.83 Million CHF | -224.83% |
| 2019 Q2 | -2.72 Million CHF | 0.0% |
| 2018 Q4 | -9.78 Million CHF | 0.0% |
| 2018 FY | -5.24 Million CHF | -339.15% |
| 2018 Q1 | -4.13 Million CHF | -83.31% |
| 2018 Q2 | -4.13 Million CHF | 0.0% |
| 2018 Q3 | -9.78 Million CHF | -136.61% |
| 2017 Q1 | -4.9 Million CHF | -7.81% |
| 2017 FY | 2.19 Million CHF | -74.09% |
| 2017 Q4 | -2.25 Million CHF | 0.0% |
| 2017 Q3 | -2.25 Million CHF | 71.88% |
| 2017 Q2 | -8.02 Million CHF | -63.76% |
| 2016 Q1 | -700 Thousand CHF | -200.29% |
| 2016 Q4 | -4.54 Million CHF | -51.5% |
| 2016 Q3 | -3 Million CHF | 23.02% |
| 2016 Q2 | -3.89 Million CHF | -456.71% |
| 2016 FY | 8.46 Million CHF | -69.7% |
| 2015 Q4 | 698 Thousand CHF | -82.55% |
| 2015 FY | 27.95 Million CHF | 5.67% |
| 2015 Q3 | 4 Million CHF | -13.15% |
| 2015 Q2 | 4.6 Million CHF | 283.79% |
| 2015 Q1 | 1.2 Million CHF | 168.84% |
| 2014 FY | 26.45 Million CHF | -15.2% |
| 2014 Q2 | 5.02 Million CHF | 0.0% |
| 2014 Q4 | -1.74 Million CHF | -187.16% |
| 2014 Q1 | 5.02 Million CHF | -35.61% |
| 2014 Q3 | 2 Million CHF | -60.17% |
| 2013 Q3 | 7.79 Million CHF | 0.0% |
| 2013 Q2 | 7.79 Million CHF | 0.0% |
| 2013 FY | 31.19 Million CHF | 0.0% |
| 2013 Q1 | 7.79 Million CHF | 0.0% |
| 2013 Q4 | 7.79 Million CHF | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 143.079% |
| IO Biotech, Inc. | -756 Thousand USD | -5297.619% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 9724.057% |
| Organovo Holdings, Inc. | -5.38 Million USD | -657.209% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21057.536% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1448.067% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 289.399% |
| Savara Inc. | -44.26 Million USD | 7.808% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -42406.25% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -474.894% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -30.924% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -392265.385% |
| Soligenix, Inc. | 97.31 Thousand USD | 42033.594% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -8498.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3292.02% |
| Century Therapeutics, Inc. | -10.8 Million USD | -277.519% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -24189.286% |
| Precision BioSciences, Inc. | 40.47 Million USD | 200.825% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 116.687% |
| Kura Oncology, Inc. | -849 Thousand USD | -4706.36% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1706.544% |
| Dyadic International, Inc. | 922.95 Thousand USD | 4521.224% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 39.19% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 61.548% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 141.202% |
| Autolus Therapeutics plc | -4.86 Million USD | -738.422% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 293.751% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 198.599% |
| GRI Bio, Inc. | 10.84 Million USD | 476.404% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -369.736% |
| IGM Biosciences, Inc. | -211.66 Million USD | 80.721% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 165.881% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2609.038% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -139293.318% |
| Opthea Limited | 21.72 Thousand USD | 187972.928% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -1944.389% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -12937.061% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -15534.483% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 134.075% |
| Surrozen, Inc. | -27.23 Million USD | -49.857% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Cingulate Inc. | -582.91 Thousand USD | -6900.298% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3286.727% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 238.857% |
| Acelyrin, Inc. | -115 Thousand USD | -35383.478% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 772.653% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -60685.628% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 126.362% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 58.453% |
| ADMA Biologics, Inc. | 88.21 Million USD | 146.256% |
| PureTech Health plc | -1.6 Million USD | -2445.602% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -40.866% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -9237.757% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5188.03% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 63.068% |
| Synaptogenix, Inc. | -6347.00 USD | -642817.914% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -79911.765% |
| ChromaDex Corporation | 50.78 Million USD | 180.358% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -205.483% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 102.322% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 133.871% |
| Better Therapeutics, Inc. | -2.72 Million USD | -1395.273% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 63.618% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 112.07% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 9.97% |
| Seer, Inc. | 7.02 Million USD | 680.703% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1341.436% |
| Gritstone bio, Inc. | -6.26 Million USD | -551.853% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3582.852% |
| Avid Bioservices, Inc. | 7.31 Million USD | 657.611% |
| Insmed Incorporated | 239.63 Million USD | 117.028% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -59.106% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 6475.938% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 58.43% |
| MediWound Ltd. | 3.57 Million USD | 1240.47% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 34105.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | 170.534% |
| OmniAb, Inc. | 14.66 Million USD | 378.216% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 132.483% |
| Zai Lab Limited | 170.9 Million USD | 123.877% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 149.838% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 357.386% |
| Veracyte, Inc. | 248.14 Million USD | 116.444% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1775.811% |
| FibroGen, Inc. | 128.9 Million USD | 131.656% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| ContextLogic Inc. | 59 Million USD | 169.163% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -27659.184% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -7235006.383% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 346.16% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.201% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 240.087% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 10589.974% |
| ImmuCell Corporation | 4.39 Million USD | 1028.193% |
| Fortrea Holdings Inc. | 424 Million USD | 109.624% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 52.643% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3582.852% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 45.977% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 110.489% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 342.849% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 17.808% |
| Vaxxinity, Inc. | -2.23 Million USD | -1726.589% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 112.488% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -260.355% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 755766.667% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -474.275% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 303.501% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1420.909% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 28087.654% |
| Apollomics, Inc. | 127 Thousand USD | 32230.709% |
| 89bio, Inc. | -273 Thousand USD | -14847.253% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 116.951% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -7796.723% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1049.141% |
| Ardelyx, Inc. | 106.66 Million USD | 138.258% |
| Pluri Inc. | 322 Thousand USD | 12772.671% |
| Prothena Corporation plc | -129.2 Million USD | 68.417% |
| Pulmatrix, Inc. | -8.22 Million USD | -396.423% |
| Celularity Inc. | 6.75 Million USD | 704.086% |
| MeiraGTx Holdings plc | 287 Thousand USD | 14318.118% |
| Omeros Corporation | -69.77 Million USD | 41.521% |
| Ainos, Inc. | -253.73 Thousand USD | -15982.26% |
| Humacyte, Inc. | -76.55 Million USD | 46.694% |
| Mesoblast Limited | -9.81 Million USD | -315.751% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -169.009% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 165.413% |
| Blueprint Medicines Corporation | 236.58 Million USD | 117.248% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -2761.571% |
| Summit Therapeutics Inc. | -2.05 Million USD | -1890.537% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -750.479% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1334.81% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 89.768% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1570.177% |
| Cytokinetics, Incorporated | -322.59 Million USD | 87.351% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 4833.298% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -11866.569% |
| Roivant Sciences Ltd. | 109.23 Million USD | 137.356% |
| Evogene Ltd. | 1.39 Million USD | 3016.798% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 7.073% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 695.1% |
| BioLineRx Ltd. | 1.1 Million USD | 3782.852% |
| Atai Life Sciences N.V. | -5000.00 USD | -816020.0% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 8327.016% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 125.288% |
| MediciNova, Inc. | 979.7 Thousand USD | 4265.131% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 51.605% |
| MiMedx Group, Inc. | 266.84 Million USD | 115.292% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 104.678% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -13063.226% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -339950.0% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6192.813% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -816020.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 46.57% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1558.106% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 119.092% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4236.451% |
| Allakos Inc. | -6.14 Million USD | -564.485% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 40.857% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 108.575% |
| BioAtla, Inc. | -103.73 Million USD | 60.662% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 83.195% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -13020.9% |
| Precigen, Inc. | 106 Thousand USD | 38596.226% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| XOMA Corporation | 3.86 Million USD | 1156.876% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 41.776% |
| Incyte Corporation | 3.44 Billion USD | 101.186% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 375.828% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 427.496% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 116.935% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -140610.345% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 313892407.692% |
| UroGen Pharma Ltd. | 73.35 Million USD | 155.63% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -52.866% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 351572.868% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -21490.476% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1107.307% |
| Chimerix, Inc. | 324 Thousand USD | 12694.444% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -92246.338% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -18366.175% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 151.52% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 7182.174% |
| Portage Biotech Inc. | -54 Thousand USD | -75466.667% |
| OncoCyte Corporation | 413 Thousand USD | 9980.387% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -907708.676% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2060809.091% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -18380981.081% |
| Purple Biotech Ltd. | -196 Thousand USD | -20719.388% |
| NextCure, Inc. | -3.68 Million USD | -1007.655% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -290.677% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Generation Bio Co. | -73.91 Million USD | 44.79% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -6008.683% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 130.167% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -17488.793% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -357596.353% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Novavax, Inc. | 639.93 Million USD | 106.377% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| Curis, Inc. | 9.81 Million USD | 515.921% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1573.395% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2260.093% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 68.494% |
| BeiGene, Ltd. | 2.07 Billion USD | 101.963% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -1359.494% |
| Alector, Inc. | -95.05 Million USD | 57.07% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 171.983% |
| Erasca, Inc. | -3.73 Million USD | -993.408% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 6.113% |
| Aura Biosciences, Inc. | -1.29 Million USD | -3051.042% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -8193.902% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -60962.146% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -144509.824% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4144.202% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.143% |
| Histogen Inc. | 3.76 Million USD | 1182.674% |
| Fortress Biotech, Inc. | 57.85 Million USD | 170.534% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 77.506% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 31489.231% |
| Galecto, Inc. | -830 Thousand USD | -4816.386% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.416% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 8023.495% |
| Molecular Templates, Inc. | 50.39 Million USD | 180.972% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -71082.361% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 111.483% |
| Amarin Corporation plc | 165.54 Million USD | 124.65% |
| TG Therapeutics, Inc. | 219.1 Million USD | 118.624% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -7096.825% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 63.28% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1037.291% |
| Onconetix, Inc. | -1.12 Million USD | -3520.233% |
| MacroGenics, Inc. | 50.52 Million USD | 180.761% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 155.592% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 314.283% |
| Adagene Inc. | 18.11 Million USD | 325.304% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 6800.493% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 266.889% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 125.853% |
| SciSparc Ltd. | 2.19 Million USD | 1958.197% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -162804.707% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -131608.734% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -9237.757% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 174.71% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 86.436% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.688% |
| Psyence Biomedical Ltd. | -240.00 USD | -17002400.0% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 141.517% |
| Clene Inc. | 533 Thousand USD | 7755.91% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4163.95% |
| GeoVax Labs, Inc. | -20.72 Million USD | -96.933% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -249.759% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 26.554% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Absci Corporation | -41.84 Million USD | 2.492% |
| XBiotech Inc. | -1.74 Million USD | -2239.794% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -4781.1% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 12.19% |
| Entera Bio Ltd. | -56 Thousand USD | -72767.857% |
| Trevena, Inc. | 1.45 Million USD | 2904.536% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 180.926% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 47.414% |
| INmune Bio, Inc. | 155 Thousand USD | 26426.452% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -20899.815% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -11459.773% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -131532.258% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -107.148% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -538948.877% |
| Jaguar Health, Inc. | 7.72 Million USD | 628.301% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 618.435% |
| NexImmune, Inc. | -1.02 Million USD | -3881.182% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -4030.162% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -72325.544% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -3975.563% |
| Kronos Bio, Inc. | 1.37 Million USD | 3074.198% |
| Innoviva, Inc. | 261.06 Million USD | 115.631% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 143.199% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.361% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 23.963% |
| Verastem, Inc. | -62 Thousand USD | -65716.129% |
| ProKidney Corp. | -3.16 Million USD | -1187.662% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Imunon, Inc. | -720 Thousand USD | -5567.461% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -13874.658% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -8256.508% |
| ImmunityBio, Inc. | -17.89 Million USD | -128.094% |
| Korro Bio, Inc. | -3.63 Million USD | -1024.132% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 130.5% |
| Kineta, Inc. | 5.43 Million USD | 851.077% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 113.009% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 269.255% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -6045.482% |
| Celularity Inc. | 6.75 Million USD | 704.086% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1116.845% |
| CalciMedica, Inc. | -58 Thousand USD | -70255.172% |
| Cibus, Inc. | 1.42 Million USD | 2969.62% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 57.91% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 240.444% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -10810.695% |
| Kodiak Sciences Inc. | -25.94 Million USD | -57.267% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -32.208% |
| Annexon, Inc. | -3.26 Million USD | -1149.036% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -1896.38% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 2.231% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3387.692% |
| Moderna, Inc. | 2.15 Billion USD | 101.894% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -10127.068% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.242% |
| Vor Biopharma Inc. | -3.49 Million USD | -1068.557% |
| Eyenovia, Inc. | - USD | Infinity% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -135920.0% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 123.593% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -555.834% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 139.199% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 105.995% |
| Immunocore Holdings plc | 248.39 Million USD | 116.428% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 48.131% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -123554.545% |
| Alkermes plc | 1.37 Billion USD | 102.968% |
| Arcellx, Inc. | 108.27 Million USD | 137.686% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -33386.242% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -2837.797% |
| Sagimet Biosciences Inc. | 2 Million USD | 2140.3% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -92.918% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -43055.835% |
| Moolec Science SA | -143.3 Thousand USD | -28374.931% |
| Biomea Fusion, Inc. | -4.2 Million USD | -871.34% |
| RenovoRx, Inc. | - USD | Infinity% |
| Geron Corporation | -123.5 Million USD | 66.96% |
| Mereo BioPharma Group plc | 7.42 Million USD | 649.502% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1032.069% |
| Royalty Pharma plc | 1.79 Billion USD | 102.275% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 41.781% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1129634.219% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -2846.282% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 17735.085% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 63.374% |
| Humacyte, Inc. | -76.55 Million USD | 46.694% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4199.106% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -357596.353% |
| Genelux Corporation | -848 Thousand USD | -4712.028% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -34338.059% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1608.794% |
| Notable Labs, Ltd. | 113 Thousand USD | 36211.504% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -80321.758% |
| Mustang Bio, Inc. | -2.22 Million USD | -1733.978% |
| Immunovant, Inc. | -231 Thousand USD | -17564.935% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Vericel Corporation | 135.57 Million USD | 130.098% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 106.407% |
| Akari Therapeutics, Plc | -4000.00 USD | -1020050.0% |
| Acasti Pharma Inc. | -11 Thousand USD | -370863.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -19842.625% |
| Vaxcyte, Inc. | -75 Million USD | 45.592% |
| Orgenesis Inc. | -5.72 Million USD | -612.769% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -3.719% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| GH Research PLC | -315 Thousand USD | -12854.286% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -10610.236% |
| PepGen Inc. | -1.18 Million USD | -3346.453% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -32030.709% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -49312.107% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 61680.949% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -935.147% |
| Belite Bio, Inc | -399 Thousand USD | -10127.068% |
| Pharming Group N.V. | 220.1 Million USD | 118.539% |
| XOMA Corporation | 3.86 Million USD | 1156.876% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -7672.571% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bionomics Limited | -434.44 Thousand USD | -9292.587% |
| Xencor, Inc. | -85.26 Million USD | 52.139% |
| Replimune Group, Inc. | -2.65 Million USD | -1436.949% |
| Pyxis Oncology, Inc. | -2 Million USD | -1940.3% |
| Cassava Sciences, Inc. | -89.42 Million USD | 54.367% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 122.945% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Turnstone Biologics Corp. | 16.5 Million USD | 347.219% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -49663.415% |
| GeoVax Labs, Inc. | -20.72 Million USD | -96.933% |
| MEI Pharma, Inc. | 49.32 Million USD | 182.725% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -10723.873% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -43055.835% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -22824.719% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -4786.946% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 555.018% |
| scPharmaceuticals Inc. | 9.78 Million USD | 517.154% |
| HilleVax, Inc. | -2.15 Million USD | -1792.672% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2291.515% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -271867.475% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Immunic, Inc. | -111 Thousand USD | -36662.162% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -177317.391% |
| Aptorum Group Limited | -1.11 Million USD | -3560.755% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -1984.065% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -543533.496% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -32600.26% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -17797.368% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 111.271% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -405889.454% |
| bluebird bio, Inc. | -4.03 Million USD | -912.556% |
| DBV Technologies S.A. | 15.72 Million USD | 359.448% |
| Compugen Ltd. | 31.45 Million USD | 229.728% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -144509.824% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11195.552% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4359.672% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 609.693% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -7046.41% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1685.315% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 266.446% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -7513.06% |
| Benitec Biopharma Inc. | 108 Thousand USD | 37883.333% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -52215.385% |
| Adicet Bio, Inc. | -6.09 Million USD | -569.17% |
| Prime Medicine, Inc. | -147.9 Million USD | 72.411% |
| Aditxt, Inc. | -111.66 Thousand USD | -36444.868% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -7643.074% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 8461.885% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -28375.726% |
| PolyPid Ltd. | -1.82 Million USD | -2139.627% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -34190.756% |
| Invivyd, Inc. | -2.02 Million USD | -1912.13% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -39349.719% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 137.173% |
| CorMedix Inc. | -205.56 Thousand USD | -19750.945% |
| Instil Bio, Inc. | -4.75 Million USD | -757.99% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2152.616% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 181.932% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -475.381% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 142.344% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3699.441% |
| AbCellera Biologics Inc. | 38.02 Million USD | 207.314% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 176.758% |
| Surrozen, Inc. | -27.23 Million USD | -49.857% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 12.88% |
| Verona Pharma plc | -679.62 Thousand USD | -5904.202% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -4531.782% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 148.919% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 55912.999% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 76.438% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1610.943% |
| AlloVir, Inc. | -398 Thousand USD | -10152.764% |
| BioVie Inc. | -229.37 Thousand USD | -17689.927% |
| Codexis, Inc. | 57.33 Million USD | 171.172% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21057.536% |
| Agenus Inc. | 139.61 Million USD | 129.228% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 80760.21% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -23238.652% |
| Viridian Therapeutics, Inc. | -1 Million USD | -3948.214% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -78.044% |
| Immix Biopharma, Inc. | -5468.00 USD | -746169.203% |
| Celcuity Inc. | -142.77 Thousand USD | -28481.234% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -26.065% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 3.573% |
| IN8bio, Inc. | -2.5 Million USD | -1531.587% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -33075.61% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 3746.649% |
| Liquidia Corporation | 14.6 Million USD | 379.493% |
| Quantum-Si incorporated | 488 Thousand USD | 8461.885% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6192.813% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 75.64% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -85.591% |
| United Therapeutics Corporation | 2.07 Billion USD | 101.971% |
| Solid Biosciences Inc. | -76.56 Million USD | 46.703% |
| Immuneering Corporation | -764.13 Thousand USD | -5240.135% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3699.441% |
| uniQure N.V. | 2.21 Million USD | 1942.257% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2047.684% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -9900.735% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 55.679% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -816020.0% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3146.301% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 3696.573% |
| Cue Biopharma, Inc. | -32.6 Million USD | -25.145% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -78.215% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -103.663% |
| Zura Bio Limited | - USD | Infinity% |
| Forte Biosciences, Inc. | -9000.00 USD | -453300.0% |
| Elevation Oncology, Inc. | -39 Thousand USD | -104530.769% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Immunome, Inc. | -8.9 Million USD | -358.134% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2059.048% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -23217.714% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1427.44% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1595.305% |
| Altimmune, Inc. | -65.37 Million USD | 37.58% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 10250.746% |
| Rallybio Corporation | -150 Thousand USD | -27104.0% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -754.218% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1751.396% |
| Moolec Science SA | -143.3 Thousand USD | -28374.931% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -123554.545% |
| NeurAxis, Inc. | 2.15 Million USD | 1992.054% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 129.105% |
| Lumos Pharma, Inc. | 2 Million USD | 2133.184% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -23217.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -38514.62% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3292.02% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 228.893% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 4833.298% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 10.411% |
| argenx SE | 1.1 Billion USD | 103.681% |
| Neurogene Inc. | -3.26 Million USD | -1150.95% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 129.286% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -74092.727% |
| CervoMed Inc. | -1.29 Million USD | -3054.387% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1005.255% |
| Sesen Bio, Inc. | 40 Million USD | 202.015% |
| AnaptysBio, Inc. | 14.78 Million USD | 376.071% |
| Design Therapeutics, Inc. | -537 Thousand USD | -7498.883% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -9456.44% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2001.491% |
| Achilles Therapeutics plc | -4.73 Million USD | -762.475% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -41968.041% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -3854.07% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 94997.674% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -4864.234% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -310023.119% |
| Palisade Bio, Inc. | 246 Thousand USD | 16687.805% |
| Beam Therapeutics Inc. | -59.67 Million USD | 31.616% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -13639.394% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -913.301% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -326.573% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 389.815% |
| Athira Pharma, Inc. | -969 Thousand USD | -4111.146% |
| Vaccinex, Inc. | -16 Million USD | -154.974% |
| HCW Biologics Inc. | -574.82 Thousand USD | -6998.869% |
| XOMA Corporation | 3.86 Million USD | 1156.876% |
| Nektar Therapeutics | 53.47 Million USD | 176.304% |
| Arvinas, Inc. | 71.8 Million USD | 156.833% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 51.108% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 34.996% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -12572.671% |
| Rezolute, Inc. | -36 Thousand USD | -113250.0% |
| Clene Inc. | 533 Thousand USD | 7755.91% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3177937.383% |
| BeyondSpring Inc. | 1.75 Million USD | 2430.44% |
| Synlogic, Inc. | -1.92 Million USD | -2020.894% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -110186.486% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -544.441% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11195.552% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -115.187% |
| Krystal Biotech, Inc. | 47.6 Million USD | 185.718% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 128.922% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 912.06% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1475.996% |
| MannKind Corporation | 136.19 Million USD | 129.962% |
| Ikena Oncology, Inc. | -50.49 Million USD | 19.183% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 137.501% |
| Gossamer Bio, Inc. | -4.38 Million USD | -830.582% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -16092.857% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -816020.0% |
| Legend Biotech Corporation | 140.92 Million USD | 128.955% |
| Mural Oncology plc | -2.56 Million USD | -1489.638% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -7305.808% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -40706.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 296.618% |
| REGENXBIO Inc. | 53.02 Million USD | 176.95% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -661.739% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -21111.696% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2256.005% |
| Vaxart, Inc. | -60.76 Million USD | 32.844% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -15428.579% |
| Cellectis S.A. | 18 Thousand USD | 226800.0% |
| Longeveron Inc. | 221 Thousand USD | 18564.253% |
| Repare Therapeutics Inc. | -80.07 Million USD | 49.037% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 103.733% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -3053.478% |
| Revolution Medicines, Inc. | -399.66 Million USD | 89.79% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -116488.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 83377.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.474% |
| Denali Therapeutics Inc. | -93.34 Million USD | 56.285% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -162804.707% |
| Veru Inc. | 7.56 Million USD | 639.339% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -26923.841% |
| Cingulate Inc. | -582.91 Thousand USD | -6900.298% |
| Passage Bio, Inc. | -3.72 Million USD | -996.641% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -338707.705% |
| Exicure, Inc. | -1.42 Million USD | -2767.604% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -10554.308% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1609.656% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 89.79% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -7859.428% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 159.898% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -27175.462% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 31.078% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 10536.317% |
| OmniAb, Inc. | 14.66 Million USD | 378.216% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 304.101% |
| Lipocine Inc. | -2.85 Million USD | -1331.379% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2114.107% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -615.267% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2609.038% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 154.18% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -62678.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 148.408% |
| Ocugen, Inc. | -33.53 Million USD | -21.675% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1190.512% |
| Q32 Bio Inc. | 578 Thousand USD | 7159.862% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -15298.491% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3078.037% |
| Equillium, Inc. | 35.95 Million USD | 213.482% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2290.51% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 8250.132% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -986982.729% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -15655.212% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 9753.381% |
| Dominari Holdings Inc. | 2.03 Million USD | 2101.275% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -22141.117% |
| vTv Therapeutics Inc. | -13.59 Million USD | -200.154% |
| Bio-Techne Corporation | 773.07 Million USD | 105.278% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 335.614% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 108.856% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3390.676% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -70.167% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 448.859% |
| Nkarta, Inc. | -5.86 Million USD | -595.28% |
| BioCardia, Inc. | -7.24 Million USD | -462.919% |
| Iterum Therapeutics plc | -1.75 Million USD | -2231.771% |